[1]
Banu ALPASLAN MESCİ, “Can Pentraxin-3 be a Candidate Marker in the Follow-Up of the Patients With Behçet’s Disease?”, Archives of Rheumatology, vol. 32, no. 2, pp. 091–095, Jun. 2017.